Ultromics
AI echocardiography platform providing automated heart disease assessment from ultrasound images.
- Headquarters
- Oxford, United Kingdom
- Company size
- 51-200 employees
- Founded
- 2017
Product overview
- Automated echocardiographic analysis for HFpEF detection
- Automated echocardiographic analysis for cardiac amyloidosis screening
- DICOM workflow integration
Buyer research
Unlock the full Ultromics profile
Create a free account and complete onboarding for buyer research and procurement details.
Create free accountAlready joined? Log in
Buyer fitUnlock buyer fit
Procurement detailsUnlock procurement details
ImplementationUnlock implementation
IntegrationsUnlock integrations
Customer evidenceUnlock customer evidence
AlternativesUnlock alternatives
VendorUnlock vendor
Is this your product?Claim this profile